Free Trial

Immunovant (IMVT) Short Interest Ratio & Short Volume

→ Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad)
Free IMVT Stock Alerts
$28.42
-0.53 (-1.83%)
(As of 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends

Immunovant Short Interest Data

Current Short Interest
9,290,000 shares
Previous Short Interest
8,960,000 shares
Change Vs. Previous Month
+3.68%
Dollar Volume Sold Short
$287.34 million
Short Interest Ratio
8.7 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
145,290,000 shares
Float Size
60,900,000 shares
Short Percent of Float
15.25%
Today's Trading Volume
981,078 shares
Average Trading Volume
1,142,729 shares
Today's Volume Vs. Average
86%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Immunovant ?

Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IMVT Short Interest Over Time

IMVT Days to Cover Over Time

IMVT Percentage of Float Shorted Over Time

Immunovant Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20249,290,000 shares $287.34 million +3.7%15.3%8.7 $30.93
4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44
4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47
3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31
3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53
2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37
2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80
1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41
1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36
12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13
12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74
11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13
11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24
10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05
10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41
9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39
9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81
8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71
8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52
7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83
7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74
6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97
6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13
5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01
5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41
4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14
4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27
3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51
3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41
2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47
2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13
1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77
1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60
12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75
12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21
11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11
11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29
10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20
10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19
9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58
Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08
8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15
8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16
7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12
7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34
6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90
6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45
5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24
5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04
4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61
4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00
3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51
3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27
2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58
2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72
1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99
1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86
12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52
12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87
11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70
11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18
10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04
10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72
9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69
9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53
8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66
8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88
7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46
7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09
6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57
6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76
5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16
5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61
4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30
4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92
3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00
3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99
2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94
2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49
1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22
1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51
12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33
12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94
11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83
11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67
10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95
10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78
9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19
9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68
8/31/20201,180,000 shares $40.07 million +26.9%3.5%2.2 $33.96
Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
8/14/2020929,700 shares $25.40 million -13.9%2.7%2 $27.32
7/31/20201,080,000 shares $24.42 million -8.5%3.1%2.5 $22.61
7/15/20201,180,000 shares $28.54 million -11.9%3.4%2.8 $24.19
6/30/20201,340,000 shares $32.63 million +205.7%5.8%3 $24.35
6/15/2020438,300 shares $11.23 million -57.5%2.4%1.2 $25.63
5/29/20201,030,000 shares $26.43 million -24.3%5.5%3.9 $25.66
5/15/20201,360,000 shares $26.33 million -11.7%7.3%5.9 $19.36
4/30/20201,540,000 shares $28.58 million +32.8%5.6%8.2 $18.56
4/15/20201,160,000 shares $20.89 million +72.5%6.0%7 $18.01
3/31/2020672,400 shares $12.78 million -17.4%3.8%4.9 $19.01
3/13/2020813,900 shares $12.65 million +8.8%16.7%7.3 $15.54
2/28/2020747,900 shares $8.23 million +6.4%15.4%5.6 $11.01
2/14/2020703,000 shares $10.59 million +5.8%14.4%4.4 $15.06
1/31/2020664,500 shares $9.85 million +48.9%13.6%3.6 $14.83
1/15/2020446,300 shares $7.01 million +41.8%9.2%2.5 $15.70
12/31/2019314,800 shares $5.06 million No Change6.5%1.9 $16.07

IMVT Short Interest - Frequently Asked Questions

What is Immunovant's current short interest?

Short interest is the volume of Immunovant shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 9,290,000 shares of IMVT short. 15.25% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest.

What is a good short interest ratio for Immunovant?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 9.0. Learn More on Immunovant's short interest ratio.

Which institutional investors are shorting Immunovant?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Walleye Trading LLC, PEAK6 Investments LLC, Twin Tree Management LP, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Immunovant?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.25% of Immunovant's floating shares are currently sold short.

Is Immunovant's short interest increasing or decreasing?

Immunovant saw a increase in short interest in May. As of May 15th, there was short interest totaling 9,290,000 shares, an increase of 3.7% from the previous total of 8,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Immunovant's float size?

Immunovant currently has issued a total of 145,290,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 60,900,000 shares.

How does Immunovant's short interest compare to its competitors?

15.25% of Immunovant's shares are currently sold short. Here is how the short interest of companies compare to Immunovant: CRISPR Therapeutics AG (18.05%), ImmunityBio, Inc. (38.03%), Krystal Biotech, Inc. (9.84%), SpringWorks Therapeutics, Inc. (14.43%), Halozyme Therapeutics, Inc. (6.80%), Arcellx, Inc. (9.67%), Iovance Biotherapeutics, Inc. (22.90%), Apogee Therapeutics, Inc. (12.30%), Denali Therapeutics Inc. (8.09%), Utz Brands, Inc. (9.09%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Immunovant stock?

Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading down $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunovant?

A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further.

How often is Immunovant's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:IMVT) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
WARNING about the death of the U.S. dollar…
Colonial Metals
The only AI company to buy
Porter & Company
Biggest Prediction of My 50-Year Career on Wall Street
Chaikin Analytics
Is Artificial Intelligence the Biggest Bubble in History?
InvestorPlace
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders